bioAffinity Technologies, Inc. (BIAFW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 17Jul 31Aug 7Aug 12Aug 19Aug 24Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.0x

Market Cap

$746445.00

MomentumView details →

1D Return

+79.00%

YTD Return

+78.49%

RSI (14)

80.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.0x

Market Cap

$746445.00

RSI (14)

80.7

MomentumView details →

1D Return

+79.00%

YTD Return

+78.49%

ProfitabilityView details →

Gross Margin

−39.57%

Net Margin

−257.33%

EBITDA Margin

−249.47%

ROE (TTM)

−402.92%

ROA (TTM)

−199.30%

Asset Turnover

0.76x

GrowthView details →

Revenue YoY

−23.17%

EPS YoY

−30.67%

FCF YoY

−48.40%

Revenue CAGR 3Y

+986.60%

EPS CAGR 3Y

+61.51%

EBITDA YoY

−33.79%

EarningsView details →

EPS (Actual)

−$0.64

EPS Surprise

69.52%

Beats (12Q)

3/12

Next Q EPS Est

−$31.50

Avg Surprise (4Q)

38.68%

Rev Surprise

−11.19%

Capital & dividendView details →

Debt/Equity

0.38x

Current Ratio

1.44x

Quick Ratio

1.41x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

5.90M

Net Income (TTM)

−15.19M

Op. CF (TTM)

−11.47M

Next earningsNov 18, 2026 →

Latest newsMore news →

bioAffinity Technologies and AvMEDICAL announced a nationwide federal healthcare distribution agreement for CyPath Lung, expanding sales reach and access to government healthcare systems.17d ago

bioAffinity Technologies, Inc. completed a private placement on August 12, 2026, issuing pre-funded warrants, Series A warrants, and Series B warrants, raising approximately $4 million in gross proceeds.22d ago

Similar companies

Prenetics Global LimitedPRENW Inotiv, Inc.NOTV Aspira Women's Health Inc.AWH iSpecimen Inc.ISPC BioNexus Gene Lab Corp.BGLC Intelligent Bio Solutions Inc.INBS Find similar companies →

Latest newsMore news →

bioAffinity Technologies and AvMEDICAL announced a nationwide federal healthcare distribution agreement for CyPath Lung, expanding sales reach and access to government healthcare systems.17d ago bioAffinity Technologies, Inc. completed a private placement on August 12, 2026, issuing pre-funded warrants, Series A warrants, and Series B warrants, raising approximately $4 million in gross proceeds.22d ago bioAffinity Technologies reported its financial results for the second quarter of 2026.28d ago